Trial Profile
Phase III trial of zoledronic acid in patients with post-menopausal osteoporosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2013
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms PMO-HORIZON
- 23 Dec 2010 Preliminary results from a substudy were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research.
- 23 Dec 2010 New trial record